METLiT

Seoul, South Korea

Drug Development Clinical Research Clinical Trials Diagnostics

METLiT can solve pharmaceutical companies' problem by providing customized MRS analysis solution with Deep learning. METLiT Specialized solution helps to determine the effectiveness of new drugs by acquiring information on direct metabolite changes in vivo, without relying on the patient's symptoms. Our solution provides quantitative and objective data to optimize clinical studies which helps to ascertain the most effective dosage and material of new drugs.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out METLiT on @MedStartr Today #DrugDevelopment #ClinicalTrials #ClinicalResearch #Diagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/yfJqYMZ_Q6E

Get Involved in METLiT

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: metlit.ai/

Disease Areas

Drug Development Clinical Trials

Technologies

Biomarker AnalysisClinical TrialsDrug DevelopmentAnalytical Instrumentation

🌐Website

What do you think of METLiT?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.